section name header

Footnotes

a Tested in dextrose 5%.

b Tested in sodium chloride 0.9%.

c Tested in both dextrose 5% and sodium chloride 0.9%.

d Tested in dextrose 5%, Ringer’s injection, lactated, and sodium chloride 0.9%.

e Refer to Appendix for the composition of parenteral nutrition solutions. TNA indicates a 3-in-1 admixture, and TPN indicates a 2-in-1 admixture.

f Tested in combination with hydrocortisone sodium succinate (Upjohn) 100 mg/L.

g Tested in combination with heparin sodium (Riker) 1000 units/L.

h Quinupristin and dalfopristin components combined.

i Ceftolozane component. Ceftolozane in a 2:1 fixed-ratio concentration with tazobactam.

j Meropenem component. Meropenem in a 1:1 fixed-ratio concentration with vaborbactam.

k Imipenem component. Imipenem in a 2:2:1 fixed-ratio concentration with cilastatin and relebactam.

l Sulbactam component. Sulbactam in a 1:1 fixed-ratio concentration with durlobactam.